Environmental Impacts on Reproductive Health: Pesticides
At the conclusion of this activity, participants will be able to:
- Discuss how pesticide exposure can affect the reproductive health of both women and men
- Identify the critical windows of susceptibility during which pesticide exposures can affect both female and male reproduction and reproductive outcomes
- Counsel patients about their specific risks and the steps they can take to reduce their risks
- Refer patients for additional information about pesticide exposure and reproductive health risks
Physicians: The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. ARHP designates this continuing medical education activity for 1.0 credit hours in Category 1 of the Physician's Recognition Award of the American Medical Association. ARHP designates this educational activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurse Practitioners and Nurses: This educational activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for 1.0 contact hour, including 0.5 pharmacology hours. Credit can be applied toward the nursing continuing requirements of most professional organizations and State Boards of Nursing.
Pharmacists: The Association of Reproductive Health Professionals (ARHP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 1.0 contact hour of continuing education credit. The assigned universal program number for Environmental Impacts on Reproductive Health: Pesticides is 463-000-09-007-L04-P.
Others: A certificate of attendance will be issued indicating that this activity is accredited for 1 hour of AMA PRA Category 1 CreditTM.
This program is sponsored by the Association of Reproductive Health Professionals.
This project is funded through grants from the Passport Foundation and the Richard and Rhoda Goldman Fund.
All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.
Advisory Committee Disclosures
- Kathleen Hill Besinque, PharmD, MSEd, FCSHP: No affiliations to disclose
- Maureen Paul, MD, MPH: No affiliations to disclose
- Barbara Sattler, RN, DrPH, FAAN: No affiliations to disclose
- Ted Schettler, MD, MPH: No affiliations to disclose
- Michael Thomas, MD: No affiliations to disclose
- Tracey Woodruff, PhD, MPH: No affiliations to disclose
- Sandy Worthington, MSN, WHNP-BC, CNM: Receives support from the Cedar Tree Foundation Grant through Planned Parenthood Federation of America.
ARHP Staff/Consultant Disclosures Deborah Shuman, Rivka Gordon, PA-C, Beth Jordan, MD, Allison Tombros Korman, MHS, Amy Swann, MA, and Wayne Shields have no affiliations to disclose.